Robert E. Ratner
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Obstetrics and Gynecology top 0.2%
- Gestational Diabetes Research and Management
Papers in
-
- Diabetes Treatment and Management 53
- Diabetes Management and Research 42
- Diabetes, Cardiovascular Risks, and Lipoproteins 33
-
- Gestational Diabetes Research and Management 13
- Co-authors
- Mark S. Fineman (6 shared papers)Jenny Han (2 shared papers)Dennis Dong Hwan Kim (2 shared papers)Alain Baron (1 shared paper)Ralph Anthony DeFronzo (1 shared paper)Sarah E. Fowler (5 shared papers)Robert R. Henry (14 shared papers)Bruce W. Bode (7 shared papers)
- Journals
- Diabetes Care (56 papers)Diabetes (12 papers)Diabetes Obesity and Metabolism (10 papers)Diabetic Medicine (8 papers)The Journal of Clinical Endocrinology & Metabolism (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert E. Ratner
190 papers receiving 18.3k citations
Robert E. Ratner's Hit Papers
Peers
Comparison fields: 5 of 164
- Endocrinology, Diabetes and Metabolism 9.8k
- Obstetrics and Gynecology 1.4k
- Surgery 4.5k
- Nephrology 707
- Pharmacy 365
Countries citing papers authored by Robert E. Ratner
This map shows the geographic impact of Robert E. Ratner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Ratner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Ratner more than expected).
Fields of papers citing papers by Robert E. Ratner
This network shows the impact of papers produced by Robert E. Ratner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Ratner. The network helps show where Robert E. Ratner may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Ratner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes Hit paper breakdown → | 2005 | 1307 |
| 2 | Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial Hit paper breakdown → | 2008 | 915 |
| 3 | Diabetic Kidney Disease: A Report From an ADA Consensus Conference Hit paper breakdown → | 2014 | 876 |
| 4 | Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association Hit paper breakdown → | 2015 | 876 |
| 5 | The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial Hit paper breakdown → | 2005 | 765 |
| 6 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations Hit paper breakdown → | 2016 | 723 |
| 7 | Diabetic Kidney Disease: A Report From an ADA Consensus Conference Hit paper breakdown → | 2014 | 716 |
| 8 | Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions Hit paper breakdown → | 2008 | 658 |
| 9 | Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects Hit paper breakdown → | 2004 | 610 |
| 10 | Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes Hit paper breakdown → | 2009 | 607 |
| 11 | Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance Hit paper breakdown → | 2011 | 604 |
| 12 | The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance Hit paper breakdown → | 2005 | 561 |
| 13 | Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis Hit paper breakdown → | 2016 | 555 |
| 14 | 2004 | 405 | |
| 15 | 2000 | 386 | |
| 16 | 2006 | 380 | |
| 17 | The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up Hit paper breakdown → | 2015 | 338 |
| 18 | 2012 | 285 | |
| 19 | 1998 | 249 | |
| 20 | 2004 | 245 |
About Robert E. Ratner
Robert E. Ratner is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology, Surgery, Physiology and Molecular Biology, having authored 193 papers that have together received 19.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (53 papers), Diabetes Management and Research (42 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (33 papers), Metabolism, Diabetes, and Cancer (23 papers), Diet and metabolism studies (18 papers), Pancreatic function and diabetes (16 papers), Gestational Diabetes Research and Management (13 papers) and Diabetes and associated disorders (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (9.8k citations), Obstetrics and Gynecology (1.4k citations), Surgery (4.5k citations), Nephrology (707 citations) and Pharmacy (365 citations). Robert E. Ratner has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Mark S. Fineman, Jenny Han, Dennis Dong Hwan Kim, Alain Baron, Ralph Anthony DeFronzo, Sarah E. Fowler, Robert R. Henry, Bruce W. Bode, Irl B. Hirsch and Vanita R. Aroda. Their work appears in journals such as Diabetes Care, Diabetes, Diabetes Obesity and Metabolism, Diabetic Medicine and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.